Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microbial Biosensors01:17

Microbial Biosensors

88
Microbial biosensors are analytical devices that utilize living microbes to detect specific substances through measurable signals. These devices consist of two main components: biosensing organisms and signal-transducing elements. Biosensing organisms, such as Escherichia coli or Saccharomyces cerevisiae, are typically housed in multiwell plates connected to transducers, enabling rapid, real-time detection of target analytes.Signal Generation MechanismWhen a target analyte—such as...
88
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

77
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
77
Influenza01:27

Influenza

87
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
87

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineered bacteria in disease diagnosis and therapy: A synthetic biology perspective.

Synthetic and systems biotechnology·2026
Same author

Antibody-drug conjugates specifically regulate tumor microenvironment: A promising strategy for pancreatic cancer treatment.

Hepatobiliary & pancreatic diseases international : HBPD INT·2025
Same author

Multiplexed tumor-mimetic dECM-chip platform for colorectal cancer: Interrogating pharmacological synergy and NK cell immunosurveillance dynamics.

Talanta·2025
Same author

Portable lab-on-a-chip platform enabling multiplex recombinant enzyme polymerase amplification detection of H5/H7/H10 avian influenza virus subtypes.

Poultry science·2025
Same author

Establishment of a microfluidic and RPA-based platform for rapid multi-sample detection of Mycoplasma pneumoniae.

Diagnostic microbiology and infectious disease·2025
Same author

Humanized dual-targeting antibody-drug conjugates specific to MET and RON receptors as a pharmaceutical strategy for the treatment of cancers exhibiting phenotypic heterogeneity.

Acta pharmacologica Sinica·2025

Related Experiment Video

Updated: May 2, 2026

High-throughput Detection Method for Influenza Virus
10:05

High-throughput Detection Method for Influenza Virus

Published on: February 4, 2012

26.3K

Autonomous microfluidic influenza A/B subtyping system using on-chip multiplex isothermal amplification for

Si-Ming Lu1,2, Jia-Long Wang3,4, Yang Li3,4

  • 1Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

AMB Express
|August 21, 2025
PubMed
Summary

A new rapid recombinase polymerase amplification (RPA) test detects multiple influenza strains in 10 minutes, outperforming traditional methods. This fast and accurate influenza detection system is ideal for point-of-care diagnostics.

Keywords:
Influenza A and B subtypesLow-resource settingsMicrofluidic devicePoint-of-care diagnosticsRNA detectionRPA

More Related Videos

Microfluidic Chip Fabrication and Method to Detect Influenza
09:43

Microfluidic Chip Fabrication and Method to Detect Influenza

Published on: March 26, 2013

15.1K
Rapid Molecular Detection and Differentiation of Influenza Viruses A and B
05:38

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B

Published on: January 30, 2017

15.8K

Related Experiment Videos

Last Updated: May 2, 2026

High-throughput Detection Method for Influenza Virus
10:05

High-throughput Detection Method for Influenza Virus

Published on: February 4, 2012

26.3K
Microfluidic Chip Fabrication and Method to Detect Influenza
09:43

Microfluidic Chip Fabrication and Method to Detect Influenza

Published on: March 26, 2013

15.1K
Rapid Molecular Detection and Differentiation of Influenza Viruses A and B
05:38

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B

Published on: January 30, 2017

15.8K

Area of Science:

  • Virology
  • Molecular Biology
  • Biotechnology

Background:

  • Influenza viruses pose a significant global health threat.
  • Existing diagnostic methods like Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR) can be time-consuming (2 hours).
  • There is a need for rapid, accurate influenza detection, especially for point-of-care applications.

Purpose of the Study:

  • To develop a rapid detection system for multiple influenza strains.
  • To overcome the limitations of existing diagnostic tests.
  • To provide a tool for timely diagnosis and epidemic control.

Main Methods:

  • Development of a recombinase polymerase amplification (RPA)-based detection system.
  • Utilized optimized primers targeting key viral proteins (M, NA, HA, PA).
  • Tested detection time, linearity, sensitivity, and specificity.

Main Results:

  • Achieved influenza strain detection in 10 minutes.
  • Demonstrated high log linearity (0.99) over a range of 1-10^6 copies/μL.
  • Clinical validation showed 100% sensitivity and specificity in distinguishing infections.

Conclusions:

  • The developed RPA system offers rapid and accurate detection of multiple influenza strains.
  • The portable platform is suitable for point-of-care (POC) applications, particularly in resource-limited settings.
  • This technology has strong potential for timely diagnosis and effective epidemic control.